By entering this website, you confirm that you are at least 21 years of age and that you are a qualified researcher or purchasing on behalf of a research institution.
All products sold by BioNex are for laboratory research purposes only. They are not intended for human or animal consumption, and no medical, therapeutic, or diagnostic use is expressed or implied.
You acknowledge that BioNex assumes no liability for misuse, misapplication, or unauthorized use of any product purchased from this website.
By clicking “I Agree,” you accept full responsibility for compliance with all applicable laws and regulations.
Your access is restricted because of your age.
$65.00
Advanced Cellular Signaling and Selective Membranolysis Studies.
When you shop PNC-27 10mg from Bionex Peptides, you are obtaining a sophisticated research tool derived from the third helix of the p53 tumor suppressor protein. PNC-27 is a membrane-active peptide that has gained significant attention in medical studies for its potential to mitigate the proliferation of malignant cells through a unique, non-apoptotic pathway.
Unlike many research chemicals that induce apoptosis, PNC-27 is studied for its ability to induce necrosis. Research suggests that:
HDM2 Targeting: The peptide specifically binds to the HDM2 (Human Double Minute 2) protein, which is reported to be over-expressed on the membranes of carcinogenic cells.
Pore Formation: This binding interaction appears to form a 1:1 complex that perforates the cancer cell membrane, creating transmembrane pores.
Membranolysis: These “holes” lead to an influx of ions and the efflux of cellular contents, resulting in direct physical disruption and cell death while leaving non-cancerous cells intact.
Peptide Name: PNC-27
Concentration: 5mg per vial
Purity: 99%+ HPLC & MS Verified
Source: Derived from p53 (ASPP2) residues
Format: Lyophilized Professional Grade Powder
Storage: Store at -20°C for maximum stability and bio-activity.
Selective Toxicity: Studies from 2009 indicate that PNC-27 shows affinity only toward cells expressing HDM2 on their surface, highlighting its potential for selective toxicity.
Structural Integrity: Research using dual-label fluorescence in 2010 suggests that PNC-27 acts as an intact peptide rather than fragments to effectively induce membranolytic activity.
Broad Spectrum Potential: Investigated across various cell lines including pancreatic cancer, ovarian cancer, leukemia, and breast tumor models (MCF-7).
America’s Premier Source: We provide the highest-grade research materials to ensure your laboratory protocols are supported by absolute consistency.
HPLC Verified Quality: Every vial of PNC-27 10mg undergoes rigorous batch testing to guarantee a 99%+ purity profile.
Rapid & Discreet Logistics: Fast, secure, and temperature-controlled shipping across the United States to protect your research timelines.